STOCK TITAN

Biofrontera Inc. - BFRIW STOCK NEWS

Welcome to our dedicated page for Biofrontera news (Ticker: BFRIW), a resource for investors and traders seeking the latest updates and insights on Biofrontera stock.

Biofrontera Inc. is a US-based biopharmaceutical company specializing in dermatological treatments, focusing on photodynamic therapy (PDT) and topical antibiotics. It commercializes a portfolio of products for conditions like actinic keratosis and impetigo. Ameluz, their licensed product, is used in combination with the RhodoLED lamp series for PDT, along with BF-RhodoLED and Xepi.

Rhea-AI Summary

Biofrontera has launched its FDA-approved RhodoLED XL lamp, a red light emitting LED device for photodynamic therapy (PDT) of actinic keratoses. Used with the Ameluz topical gel, also FDA-approved, the RhodoLED XL is designed to treat mild-to-moderate actinic keratoses on the face and scalp. The device features an expanded treatment area and advanced positioning sensors to optimize energy delivery. It was first shipped on June 10, 2024, and has received positive feedback from dermatology practices, including Cleaver Dermatology. This launch aligns with Biofrontera's commitment to innovation in dermatologic care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.35%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.24%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.17%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
conferences

FAQ

What is Biofrontera Inc.'s core focus?

Biofrontera Inc. specializes in dermatological treatments, particularly utilizing photodynamic therapy and topical antibiotics.

What products does Biofrontera Inc. offer?

Biofrontera Inc. offers a portfolio of products for conditions such as actinic keratosis and impetigo, including their licensed product Ameluz.

What is Ameluz used for?

Ameluz is a prescription drug approved for use in combination with the RhodoLED lamp series for photodynamic therapy.

What sets Biofrontera Inc. apart in the pharmaceutical industry?

Biofrontera Inc. stands out for its focus on dermatological treatments and innovative approaches like PDT.

Where is Biofrontera Inc. based?

Biofrontera Inc. is based in the United States.

How can I learn more about Biofrontera Inc.'s products?

For more information about Biofrontera Inc.'s products, you can contact them directly or visit their website.

What is the complementary product to Ameluz?

BF-RhodoLED is the complementary product to Ameluz for photodynamic therapy.

What is Xepi used for?

Xepi is used for the treatment of impetigo, a bacterial skin infection.

How can I contact Biofrontera Inc. for investor relations?

For investor relations inquiries, you can contact Andrew Barwicki at 1-516-662-9461 or email ir@bfri.com.

Where can I find information about the RhodoLED XL lamp?

To request information about the RhodoLED XL lamp, please visit https://us.ameluz.com/contact-us.

Biofrontera Inc.

Nasdaq:BFRIW

BFRIW Rankings

BFRIW Stock Data

5.09M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
WOBURN